JPRN-UMIN000023441已完成未知
Impact on body composition and Sugar metabolism and Lipid metabolism by Diet therapy of BCAA or EPA added diet to patients with obesity type 2 diabetes - Impact on body composition and Sugar metabolism and Lipid metabolism by Diet therapy to patients with obesity type 2 diabetes
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.expectant and nursing mothers 2.ckd classification 3 period or more 3.cirrhosis of the liver 4.chronic pancreatitis (decompensated stage) 5.gastrointestinal disorders 6.there is a history of severe hypoglycemia 7.some of the heart pacemaker implantation 8.some of the contracture 9.if there is a taking of sglt2 inhibitors as drug therapy
研究者
相似试验
已完成
不适用
Effects for glucose metabolism, body composition, and circulatory dynamics of SGLT2 inhibitorType 2 diabetes mellitusJPRN-UMIN000017195Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki30
已完成
不适用
Body compositional and endocrine-metabolic changes by long-term lifestyle intervention with health education, diet (Almased®), physical activity or a combination of diet and physical activity in obese personsDietoverweightE66.0Obesity due to excess caloriesDRKS00000010niversitätsklinikum Freiburg114
已完成
不适用
se of insulin sensitisers to revert metabolic syndromeISRCTN58810841Hospital Sant Joan de Deu (Spain)52
进行中（未招募）
不适用
Effects on insulin sensitivity and body composition of combination therapy with growth hormone (GH) and insulin-like growth factor-I (IGF-I) in growth hormone deficient adults with impaired glucose tolerance or diabetes - GH-IGF-IEUCTR2009-011534-10-SEKarolinska University Hospital
招募中
4 期
Effect of Empagliflozin on Body Composition and KetonesDiabetes MellitusIntolerance, Pancreas FatNCT03877406Seoul National University Bundang Hospital200